Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Forskohlii and Improved Olfactory Function

1 of 1 paper
  • Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19.

    • 2024-07-13
    • RCT · n = 285
    • European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 281(11)
      • Mohamed H Abdelazim
      • Faisal Alsenani
      • Mohammed Alnuhait
      • Abdullah S Alshammari
      • Abdullah H Altemani
      • Eyad A Althagafi
      • Dania S Waggas
      • Ahmed H Abdelazim
      • Adnan Alharbi
    • High evidence
    • Large Human Trial
    • Clinical

    Subjects administered forskolin capsules demonstrated a significant enhancement in their composite TDI (threshold, discrimination and identification) score, suggesting a notable amelioration in olfactory functionality.

    Effect
    Beneficial
    Effect size
    Moderate
    Significant
    Yes
Back to top